We do not diagnose disease or recommend a treatment protocol or dietary supplement for the treatment of disease. You should share this information with your physician who can determine what nutrition and disease treatment regimen is best for you. Ask your physician any questions you have concerning your medical condition. You can search this site or the web for topics of interest that I may have written (use Dr Simone and topic).
“We provide truthful information without emotion or influence from the medical establishment, pharmaceutical industry, national organizations, special interest groups or government agencies.” Charles B Simone, M.MS., M.D.
CORPORATE TAKEOVERS ARE CHANGING U.S. HEALTHCARE
https://tinyurl.com/4d6jywuk
https://www.simonesuperenergy.com/wp-content/uploads/2025/11/CORPORATE-TAKEOVERS-ARE-CHANGING-U.S.-HEALTHCARE.wav
In exam rooms and hospital corridors across the country, a quiet shift is underway. Increasingly, the people and institutions delivering care are no longer just clinicians and community-based organizations, but large investors and profit-driven corporations—especially private equity firms—rapidly buying up hospitals, nursing homes, and physician practices. While this influx of capital can modernize facilities and expand services, it also introduces a deeper tension: in health care, the pursuit of profit does not always align with the needs of patients.
That tension is most visible where patients are most vulnerable. In nursing homes, where quality can be difficult to measure and residents depend heavily on staff, evidence has linked private equity ownership to lower staffing levels, diminished quality, and even higher mortality. Financial strategies designed to maximize returns—heavy borrowing, dividend payouts, and sale-leaseback real estate deals—can drain resources from care delivery. In some communities, particularly rural and low-income areas, these practices have contributed to hospital closures and reduced access to essential services.
Beyond hospitals, the structure of care itself is changing. Health care is increasingly delivered through retail-style models: urgent care chains, corporate-owned specialty practices, and concierge clinics that promise speed, convenience, and personalized service. These innovations can improve efficiency, but they also risk fragmenting care and widening inequality. Concierge medicine, for example, offers exceptional access—but primarily for those who can afford it—leaving others with fewer options and longer waits.
Meanwhile, consolidation is driving up costs. Since 2008, roughly 1,000 hospitals have merged, strengthening market power and, in some cases, raising prices dramatically without corresponding improvements in wages or patient outcomes. Behind the scenes, corporate entities often exert influence through management-services organizations, shaping clinical decisions and potentially pressuring physicians toward more profitable treatments.
Some states are beginning to push back. Oregon has moved to close loopholes that allow corporations to control physician practices indirectly, while Massachusetts has taken steps to limit risky financial arrangements and increase oversight of acquisitions. These efforts are important—but they are not enough.
If health care is to remain centered on patients rather than investors, policymakers must act more decisively. That starts with transparency: patients deserve to know who owns and controls their care. It requires enforcing minimum staffing and quality standards, and reforming Medicare and Medicaid payment systems so they no longer reward consolidation over value. Antitrust enforcement must also evolve to address not just higher prices, but subtler harms like declining care quality, workforce cuts, and concentrated market power.
More targeted reforms are also within reach. Regulators can block mergers that concentrate physician practices, and states can strengthen laws that limit corporate control of medicine, including restricting private equity ownership. Payment policies should ensure that identical services are reimbursed equally regardless of where they are delivered, removing incentives for hospital systems to absorb independent practices. Federal regulators can reduce overpayments in programs like Medicare Advantage and curb misuse of drug pricing programs that encourage unnecessary consolidation. Governments can also ban contractual “gag clauses” that prevent physicians from speaking out about corporate interference, while requiring clear disclosure of ownership structures.
In some cases, stronger measures may be necessary, including breaking up dominant health care corporations or restricting further acquisitions by large, profit-driven entities.
But policy alone is not enough. Physicians remain the moral center of the health care system. Their professional obligation is not to shareholders, but to patients. Independent physician practices, in particular, have shown they can deliver high-quality, cost-effective care while preserving the personal relationships that define good medicine. By speaking out—through professional societies, public advocacy, and direct engagement with policymakers—physicians can help ensure that the system evolves in ways that prioritize patient dignity, access, and quality.
Corporate takeover of the American health care system is putting profits ahead of people and demands a coordinated policy response. By strengthening oversight, reforming payment systems, increasing transparency, and protecting clinical independence, policymakers can realign the system with its core mission: delivering high-quality, patient-centered care. The stakes are too high to ignore. Patients are not commodities, and health care should not be treated as just another market.
Policy Statement: Addressing Corporate Consolidation in U.S. Health Care
https://www.simonesuperenergy.com/wp-content/uploads/2025/11/Policy-Statement-Addressing-Corporate-Consolidation-in-U.S.-Health-Care.wav
The rapid expansion of corporate ownership in U.S. health care—particularly by private equity firms and large, profit-driven entities—poses growing risks to patient care, affordability, and equity. While investment can support innovation and infrastructure, current trends in consolidation and financialization increasingly prioritize returns over patient outcomes, especially in vulnerable settings such as nursing homes and community hospitals. Policymakers must act to ensure that the health care system remains centered on patients, not investors.
Policy Priorities
-
Strengthen Oversight of Consolidation
Federal and state antitrust authorities should more rigorously review and, when necessary, block mergers and acquisitions that concentrate market power among hospitals, physician practices, and insurers. Oversight must extend beyond price effects to include impacts on care quality, staffing, access, and health equity. -
Reinforce the Corporate Practice of Medicine
States should strengthen and enforce laws that limit corporate control over clinical decision-making, including closing loopholes involving management-services organizations (MSOs). Consideration should be given to restricting or prohibiting private equity ownership of physician practices. -
Reform Payment Policies to Discourage Consolidation
Medicare and commercial insurers should align payment rates across care settings so that identical services are reimbursed equally, eliminating incentives for hospital acquisition of independent practices. Policymakers should also reduce excess payments in programs such as Medicare Advantage that may fuel further consolidation. -
Increase Transparency in Health Care Ownership
Patients and regulators should have clear, accessible information about who owns and controls health care organizations. Mandatory disclosure requirements should apply to hospitals, physician practices, and related entities. -
Protect Quality of Care and Workforce Standards
Governments should establish and enforce minimum staffing levels and quality benchmarks, particularly in high-risk settings such as nursing homes. Financial practices that extract value at the expense of care—such as excessive debt loading or sale-leaseback arrangements—should be subject to stricter scrutiny. -
Limit Financial Practices That Undermine Care Delivery
Policymakers should regulate or restrict practices that divert resources from patient care, including certain real estate transactions and the misuse of programs like the 340B Drug Pricing Program by non–safety-net institutions. -
Safeguard Clinical Independence and Accountability
Governments should prohibit contractual gag clauses that prevent clinicians from reporting inappropriate corporate influence over medical decisions. Protections for whistleblowers and professional autonomy must be strengthened. -
Promote Competition and Consider Structural Remedies
Where market concentration has already reduced competition and harmed patients, policymakers should consider structural remedies, including divestitures or the breakup of dominant health care entities.
Role of Physicians
Physicians play a critical role in maintaining the integrity of the health care system. Guided by their ethical obligation to prioritize patient welfare, they should advocate for policies that protect access, quality, and equity. Supporting independent practice models and engaging in public and policy discussions are essential to ensuring that health care remains a public good rather than a purely commercial enterprise.
Conclusion
The corporatization of health care demands a coordinated policy response. By strengthening oversight, reforming payment systems, increasing transparency, and protecting clinical independence, policymakers can realign the system with its core mission: delivering high-quality, patient-centered care.
Op-Ed
Title: When Profit Comes Before Patients
Across the United States, hospitals, nursing homes, and doctor’s offices are increasingly being purchased by private equity firms and large corporations. These investors often promise efficiency, innovation, and financial stability. But too often, the result is a health care system that prioritizes profits over patients.
Health care is not like other industries. Patients are often vulnerable, and quality is difficult to measure—especially in places like nursing homes. When profit becomes the primary goal, patient care can suffer. Research has linked private equity ownership of nursing homes to lower staffing levels, poorer quality care, and higher mortality rates.
Corporate consolidation is also driving costs higher. Since 2008, nearly 1,000 hospitals have merged, giving large systems greater market power and pushing prices up by as much as 65%. Meanwhile, wages for many health care workers have remained stagnant. Financial strategies such as sale-leaseback real estate deals allow investors to extract profits while leaving hospitals with heavy debts, sometimes forcing service cuts or closures—particularly in rural and low-income communities.
Outside hospitals, health care is increasingly being treated like retail. Urgent care centers, retail clinics, and concierge practices emphasize convenience and customer satisfaction. While these models can improve efficiency, they often raise costs and worsen inequality. Concierge medicine, for example, offers highly personalized care but primarily serves wealthier patients.
Physicians are also feeling the pressure. Corporations frequently use management-services organizations to control medical practices behind the scenes, potentially influencing doctors to prioritize profitable procedures rather than medically necessary ones.
States are beginning to act. Oregon recently passed legislation limiting corporate control of physician practices, and Massachusetts has increased oversight of risky financial arrangements that contributed to hospital failures.
But more action is needed. Policymakers should require transparency about who owns health care facilities, strengthen antitrust enforcement, set minimum staffing standards, and prevent financial practices that undermine patient care.
Physicians have a unique responsibility to speak out. Their profession is built on protecting human dignity and reducing suffering. By advocating for policies that prioritize patients over profits, they can help ensure that health care remains a public good—not just a business opportunity.
When Profit Comes Before Patients
Across the United States, hospitals, nursing homes, and doctors’ offices are increasingly being bought by large corporations and private equity firms. These investors often promise efficiency, modernization, and new funding for struggling health systems. But when health care is treated primarily as a financial asset, patients often pay the price.
Health care is fundamentally different from most industries. Patients are often vulnerable, quality is difficult to measure, and decisions can carry life-or-death consequences. When profit becomes the central objective, the goals of investors and the needs of patients can diverge.
Evidence increasingly shows the risks. Private equity ownership of nursing homes has been linked to lower staffing levels, poorer quality of care, and higher mortality rates. Financial strategies used by corporate owners—such as heavy borrowing or selling hospital buildings and leasing them back—can extract short-term profits while leaving facilities burdened with debt. In some cases, these pressures lead to service cuts or even hospital closures, particularly in rural and low-income communities that already face limited access to care.
At the same time, health care outside hospitals is being reshaped to resemble retail. Corporate-owned urgent care centers, retail clinics, and concierge practices emphasize convenience and customer satisfaction. These models can sometimes improve efficiency, but they also risk increasing costs and widening inequality. Concierge medicine, for instance, offers personalized care primarily to affluent patients, leaving fewer physicians available for everyone else.
Corporate consolidation is also driving up prices. Since 2008, roughly 1,000 hospitals have merged, strengthening market power and increasing costs for patients while wages for many health care workers have remained stagnant. Behind the scenes, corporations often control physician practices through management-services organizations that influence how practices operate and what services they prioritize.
Some states are beginning to respond. New laws in places like Oregon are aimed at limiting corporate control over medical practices, while Massachusetts has increased oversight of financial arrangements that contributed to hospital failures. These steps are important, but they are only the beginning.
Policymakers should require transparency about who owns health care facilities, strengthen oversight of mergers and acquisitions, establish minimum staffing and quality standards, and ensure that antitrust enforcement addresses harms beyond rising prices—such as declining quality of care and reduced access for vulnerable communities.
Physicians also have a responsibility to speak out. Their profession is grounded in protecting human dignity and reducing suffering. When financial incentives threaten patient care, silence is not neutral—it allows harmful systems to continue.
Health care should never be just another market opportunity. It is a public trust. If policymakers, physicians, and communities act together, the system can remain focused on what matters most: the health and well-being of patients.
When Profit Comes Before Patients
Across the United States, hospitals, nursing homes, and doctors’ offices are increasingly being purchased by large corporations and private equity firms. These investors promise efficiency, modernization, and fresh capital for struggling health systems. Sometimes they deliver. But too often, the growing corporatization of health care shifts the focus away from patients and toward profits.
Health care is not like most industries. Patients are often vulnerable, quality is difficult to measure, and decisions carry life-or-death consequences. When financial return becomes the primary objective, the goals of investors and the needs of patients can diverge in dangerous ways.
Evidence already points to troubling outcomes. Studies have linked private equity ownership of nursing homes to lower staffing levels, poorer quality of care, and higher mortality rates. Financial strategies designed to maximize returns—such as loading hospitals with debt or selling hospital buildings and leasing them back at high rates—can drain resources from patient care. In some cases, these practices leave health systems financially fragile, forcing service cuts or even closures that disproportionately harm rural and low-income communities.
One common strategy illustrates the problem. In sale-leaseback arrangements, a hospital sells its building to a real estate investor and then leases it back. The transaction generates immediate cash for investors but saddles the hospital with long-term rental obligations. To meet those costs, facilities may cut staff, eliminate less profitable services such as obstetrics, or reduce investment in equipment and maintenance. Over time, the quality of care can decline while investors continue collecting profits.
Corporate consolidation has also reshaped the health care market. Since 2008, roughly 1,000 hospitals have merged, giving large systems greater market power and pushing prices up significantly for patients and insurers. Meanwhile, wages for many health care workers have barely kept pace. Patients ultimately face higher costs without necessarily receiving better care.
Outside hospitals, American medicine is increasingly organized like a retail marketplace. Urgent care centers, retail clinics, and concierge practices promise convenience, shorter wait times, and personalized attention. These innovations can improve access in some situations. But they also risk widening inequality. Concierge medicine, for example, offers highly individualized care—often to patients who can afford large membership fees—while reducing the number of physicians available to serve broader communities.
Physicians themselves are feeling the pressure of this shift. Corporate investors frequently use management-services organizations to control medical practices behind the scenes. While physicians technically retain ownership in some arrangements, corporate managers often influence staffing, scheduling, and the types of services emphasized. This structure can create subtle but powerful incentives to prioritize lucrative procedures rather than the care patients most need.
To be clear, corporate investment is not inherently harmful. In some cases, it can bring much-needed capital, modernize facilities, and standardize practices in ways that improve efficiency. But the current regulatory framework often fails to guard against situations where financial incentives undermine patient care.
States are beginning to respond. Some have moved to restrict corporate control over physician practices or increase oversight of hospital acquisitions and complex financial transactions. These efforts reflect growing concern that existing laws—particularly antitrust rules—focus too narrowly on price increases while overlooking other harms such as declining quality, reduced staffing, and loss of access in vulnerable communities.
Much more can be done. Policymakers should require clear transparency about who owns health care facilities and how profits are distributed. They should strengthen oversight of mergers and acquisitions that concentrate market power. Minimum staffing and quality standards—especially in nursing homes—should be enforced to protect patient safety. Payment systems in programs like Medicare and Medicaid should also be reformed so they do not reward consolidation or encourage financial engineering.
Physicians also have a critical role to play. The medical profession is grounded in a commitment to reduce suffering and protect human well-being. When financial structures threaten that mission, physicians cannot remain silent. By engaging with policymakers, medical societies, and their communities, they can advocate for reforms that keep patient care at the center of the health system.
Health care should never be treated as just another investment opportunity. It is a public good and a moral commitment. The United States must ensure that the institutions responsible for caring for its most vulnerable people are guided first by the needs of patients—not the demands of investors.
